TearLab®/LipiView®/LipiFlow®

Diagnosing and treating dry eyes

A large segment of the population suffers from dry eye symptoms. We use advanced technology to diagnose the causes and provide treatment for dry eye.

TearLab® provides information about tear composition to help diagnose the severity of dry eye and to manage patient progress with treatments.​

The leading cause of dry eye symptoms is Meibomian Gland Dysfunction (MGD), a condition that occurs when the protective lipid (oil) that normally flows from meibomian glands in the eyelid is slowed or stopped due to blockage in the glands.
LipiView® II with Dynamic Meibomian Imaging™(DMI™) is the only instrument available that assesses both meibomian gland function and structure to detect MGD in its earliest stages.

It accurately measures lipid layer thickness, evaluates blink rate, and visualizes meibomian gland structure.

With precise heat and pulsation, LipiFlow®, the only FDA-approved device to treat MGD, removes gland blockage, allowing them to resume natural production of oil needed for healthy tears.